SAFEs and ASAs both let startups take investment upfront and issue shares later. For UK founders, the choice between the two usually boils down to:

  • 1. who is investing;
  • 2. whether SEIS or EIS relief matters; and
  • 3. what will leave the company in the best shape for its next funding round.

What is an ASA?

Under an Advance Subscription Agreement (ASA), an investor pays for shares in advance and receives them when an agreed conversion event occurs, typically the earlier of:

  • 1. a funding round meeting the agreement’s qualifying financing threshold;
  • 2. a sale or other exit; or
  • 3. a six-month longstop.

An ASA is typically used where a company wants to bring in funds quickly without undertaking a full priced round (usually ahead of a Seed or Series A round). ASAs are familiar to most UK VC funds and angels in the early-stage market and are popular due to their standardised form and potential eligibility for SEIS/EIS relief.

What is a SAFE?

Simple Agreements for Future Equity (SAFEs) were first introduced to the US VC market by Y Combinator and are increasingly used by UK startups raising from US VCs. SAFEs also let startups take investment upfront and issue shares later, usually on a priced funding round of a predetermined size. When this priced funding round happens, the SAFE will convert at the same time, either at an agreed discount, on a valuation cap, or both, depending on the agreement.

SAFEs may use either a pre-money or post-money valuation cap. Y Combinator’s current template uses a post-money cap, and post-money SAFEs are now commonly encountered in the market. Broadly, a post-money cap is used to calculate the investor’s ownership by reference to the company’s capitalisation after accounting for the relevant SAFE investment, but before the new money invested in the priced round. This generally gives the parties more certainty over the proportion of equity being sold under the SAFE. Keep in mind that the precise outcome will depend on the SAFE’s definition of company capitalisation, and further SAFEs/ASAs can increase the dilution borne by founders and existing shareholders.

Some SAFEs also give the investor a pro-rata participation right in the next round. This can often be a positive, but should be checked against the company’s existing articles of association and any shareholders’ agreement for existing pre-emption rights (which may create a conflict). An off-the-shelf US form may also need adapting for the company’s UK constitution, tax position and fundraising plans.

ASAs and SAFEs: the key differences

IssueASASAFE
FamiliarityPopular with UK angels and early-stage investors.Common among US VCs and growing in popularity in the UK.
Conversion triggersTypically: (1) a funding round meeting the agreement's qualifying financing threshold; (2) a sale or other exit; or (3) the contractual longstop.Typically: (1) an equity financing; (2) a liquidity event, such as a sale or IPO; or (3) a dissolution or insolvency event.
LongstopYes. No more than six months where S/EIS relief is intended.No. Standard US-style SAFEs have no equivalent fixed longstop.
SEIS/EIS eligiblePotentially. HMRC expressly addresses ASAs in its published guidance, but relief is dependent on several factors such as the shares issued, the investor, use of funds, share rights, timing and the form of document.Not without material amendment.
Treatment on an insolvency eventTypically provide for an automatic share issue on a specified insolvency or exit event. An ASA intended to follow HMRC's EIS approach should not give the investor a right to repayment or refund.Depends on the form. Some SAFEs entitle the investor to a cash payment on a dissolution event, subject to the agreed priority and the creditor claims. Expert advice is recommended here.

Pros and cons of ASAs

Advantages

ASAs are familiar to many UK investors and are expressly considered in HMRC’s published EIS guidance. Where SEIS/EIS relief is important, that familiarity can reduce friction and help the parties move quickly.

Points to watch

ASAs intended to qualify for SEIS/EIS relief should not offer a refund or interest, and the longstop date should not exceed six months.

Unlike SAFEs, the presence of a longstop conversion means that if the intended future funding round slips, an ASA can convert before other instruments issued by the company.

Pros and cons of SAFEs

Advantages

For a startup targeting US investment, using a document the VC and its lawyers know can save time and cost. A SAFE may also suit a company where SEIS/EIS is not relevant (such as companies carrying on activities excluded from SEIS and EIS relief). Because SAFEs do not typically carry a fixed longstop, a sequence of SAFEs issued on the same valuation terms and with the same conversion triggers would ordinarily convert together.

Points to watch

The absence of a longstop means SAFEs can sit overhanging the cap table until a conversion event occurs. The inclusion of certain repayment provisions can give a SAFE debt-like characteristics or affect whether it is classified as equity or a financial liability for accounting purposes.

SEIS and EIS: tread carefully

SEIS/EIS eligibility can be attractive to UK investors, but using an ASA does not guarantee relief. Eligibility depends on the company, its activities, the investor, the use of funds, the shares and the documentation. If relief matters, advice should be sought on the detailed rights and share issue mechanics, and Blake Morgan can help in this regard. Companies can seek HMRC advance assurance in relation to an ASA, but this does not guarantee that relief will ultimately be available.

Use the form your investors know, but plan for the round ahead

Investor familiarity can be the difference between a quick bridge round and weeks of negotiation. A UK investor seeking SEIS/EIS may expect an ASA; a US VC may insist on its SAFE. Using a familiar form reduces friction and encourages the speed these agreements were intended to provide.

However, it is important to keep one eye on future fundraising and optics. Companies issuing a mixture of ASAs and SAFEs can find themselves navigating different caps, discounts, longstops and conversion events. By the priced round, some may have converted and others may still be outstanding. The result is a harder cap table to explain to future investors, and more work for the incoming lead investor to unpick. A clear and coherent fundraising narrative can often be an overlooked factor in early bridge rounds. Blake Morgan can help founders plan successive tranches with the priced round in view.

How do ASAs and SAFEs compare with convertible loan notes?

Convertible loan notes (CLNs) are fundamentally debt instruments which may later convert into equity. They may suit investors seeking interest, repayment rights or stronger downside protection than they might typically expect under an ASA or SAFE. These protections can disadvantage a startup if debt accrues interest or becomes repayable.

Which should you choose?

There is no universal answer. An ASA may suit a UK raise where SEIS/EIS is central; a SAFE may reduce friction with US VCs; and a CLN may be appropriate where investors require genuine debt protection. The sensible choice is the form that works for the target investors now without complicating the priced round later.

Frequently asked questions

Is a SAFE the same as an ASA?

No. They serve a similar purpose, but their origins, terms, conversion mechanics and eligibility for SEIS/EIS relief differ.

Do investors get shares straight away?

Usually not. The subscription funds are paid upfront and shares are issued when a contractual conversion event occurs.

What happens if there is no round before an ASA’s longstop?

The ASA should provide for an automatic share issue on the longstop. HMRC generally expects the longstop for SEIS/EIS-focused ASAs to be no more than six months after signing.

Does an ASA or SAFE investor have shareholder rights before conversion?

Usually not merely by holding the instrument. Voting, information and other contractual rights depend on the document, but statutory shareholder rights generally arise only once shares have been issued and the investor has become a member.

When can an ASA investor claim SEIS or EIS relief?
Paying funds under an ASA does not by itself entitle the investor to relief. Relief is considered by reference to the qualifying shares when they are issued, subject to the company, investor and investment satisfying all applicable requirements.

Can an ASA be refunded?

An ASA intended to follow HMRC’s EIS approach should not allow for a refund. HMRC also expects no interest and no right to vary, cancel or assign it.

Do I need a lawyer?

These documents are short, but the cap, discount and conversion terms affect dilution, investor rights may conflict with existing documents, and tax relief can be lost if the structure is unsuitable. It is important to structure these instruments with future rounds in mind and to avoid dilution stacking. Advice is particularly important for US SAFE forms or mixed instruments.

How Blake Morgan can help

Choosing between an ASA, SAFE and CLN is a fundraising decision, not simply a document choice. Blake Morgan’s corporate team can help founders select and negotiate the right form, adapt US SAFEs for a UK company, coordinate with tax advisers on SEIS/EIS, and plan successive investments so that the company reaches its priced round with a coherent capital structure.

This note provides general information only and does not constitute legal, tax, accounting or investment advice. The appropriate structure and the availability of SEIS or EIS relief depend on the particular circumstances. Specific advice should be obtained before entering into an ASA, SAFE or convertible loan note.

Do you need legal advice on venture and growth capital?

Contact our corporate team

Arrange a call

Explore more insights